LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 43

Search options

  1. Article: Measurement of glycosylated ferritin with Concanavalin A: Assay design, optimization and validation

    Raynor, Alexandre / Peoc'h, Katell / Boutten, Anne

    Journal of chromatography. 2022 Apr. 01, v. 1194

    2022  

    Abstract: Ferritin is the major iron-storage glycoprotein found in all tissues. Ferritin glycosylation can be assessed by the differential affinities of ferritin glycoforms for Concanavalin A (ConA), a lectin. The fraction of serum ferritin bound to ConA is called ...

    Abstract Ferritin is the major iron-storage glycoprotein found in all tissues. Ferritin glycosylation can be assessed by the differential affinities of ferritin glycoforms for Concanavalin A (ConA), a lectin. The fraction of serum ferritin bound to ConA is called “glycosylated ferritin” (GF). Low GF reflects macrophagic activation and is an essential biomarker used in adult-onset Still's disease (AOSD), macrophage activation syndrome (MAS) and Gaucher disease diagnosis and therapeutic management. To date, no complete assay description and method validation according to the ISO 15189 standard has been published. This study aimed to describe and validate our method used for GF measurement and describe GF values observed in patients. Ferritin glycoforms were separated based on their affinities for ConA using commercially available TRIS-barbital buffer, Sepharose and ConA/Sepharose 4B gels. Ferritin concentrations were measured on the Siemens Dimension Vista 1500®. We analysed 16,843 GF values obtained between 2000 and 2021 from our database of patients. Optimal separation of ferritin glycoforms was obtained by 15-min incubation of serum with ConA/Sepharose at pH 8. The optimized volume were 0.4 mL for total serum ferritin (TSF) 30–1000 µg/L and 0.5 mL for TSF 1000–2500 µg/L. Serum with higher TSF should be pre-diluted in the TRIS-barbital buffer. Reproducibility of ferritin measurement in the TRIS-barbital buffer matrix was excellent (intra-assay CV < 1%; inter-assay CV < 4%). Reproducibility of GF assay was good (intra-assay CV < 10% for low and high ferritin samples, respectively; and inter-assay CV < 10%). Inter-operator variability was 21.6% for GF < 20%. Ferritin was stable for up to 3 days in the TRIS-barbital buffer. An inter-laboratory exchange program conducted with another French hospital showed good agreement between results. In our database, <20% GF levels were scarce, compatible with the low prevalence of Still's disease, MAS, and Gaucher disease. The 95% confidence interval for GF was [26–58]%, lower than values described in the literature for healthy individuals. Thanks to good performances, this technique can become readily available for laboratories servicing patients with AOSD, MAS (including severe COVID-19 patients) and Gaucher disease patients.
    Keywords COVID-19 infection ; agarose ; biomarkers ; blood serum ; chromatography ; concanavalin A ; confidence interval ; databases ; disease diagnosis ; ferritin ; genetic disorders ; glycoproteins ; glycosylation ; hospitals ; macrophage activation ; pH ; therapeutics
    Language English
    Dates of publication 2022-0401
    Publishing place Elsevier B.V.
    Document type Article
    ISSN 1570-0232
    DOI 10.1016/j.jchromb.2022.123184
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  2. Article ; Online: Measurement of glycosylated ferritin with Concanavalin A: Assay design, optimization and validation.

    Raynor, Alexandre / Peoc'h, Katell / Boutten, Anne

    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

    2022  Volume 1194, Page(s) 123184

    Abstract: Introduction: Ferritin is the major iron-storage glycoprotein found in all tissues. Ferritin glycosylation can be assessed by the differential affinities of ferritin glycoforms for Concanavalin A (ConA), a lectin. The fraction of serum ferritin bound to ...

    Abstract Introduction: Ferritin is the major iron-storage glycoprotein found in all tissues. Ferritin glycosylation can be assessed by the differential affinities of ferritin glycoforms for Concanavalin A (ConA), a lectin. The fraction of serum ferritin bound to ConA is called "glycosylated ferritin" (GF). Low GF reflects macrophagic activation and is an essential biomarker used in adult-onset Still's disease (AOSD), macrophage activation syndrome (MAS) and Gaucher disease diagnosis and therapeutic management. To date, no complete assay description and method validation according to the ISO 15189 standard has been published. This study aimed to describe and validate our method used for GF measurement and describe GF values observed in patients.
    Materials and methods: Ferritin glycoforms were separated based on their affinities for ConA using commercially available TRIS-barbital buffer, Sepharose and ConA/Sepharose 4B gels. Ferritin concentrations were measured on the Siemens Dimension Vista 1500®. We analysed 16,843 GF values obtained between 2000 and 2021 from our database of patients.
    Results: Optimal separation of ferritin glycoforms was obtained by 15-min incubation of serum with ConA/Sepharose at pH 8. The optimized volume were 0.4 mL for total serum ferritin (TSF) 30-1000 µg/L and 0.5 mL for TSF 1000-2500 µg/L. Serum with higher TSF should be pre-diluted in the TRIS-barbital buffer. Reproducibility of ferritin measurement in the TRIS-barbital buffer matrix was excellent (intra-assay CV < 1%; inter-assay CV < 4%). Reproducibility of GF assay was good (intra-assay CV < 10% for low and high ferritin samples, respectively; and inter-assay CV < 10%). Inter-operator variability was 21.6% for GF < 20%. Ferritin was stable for up to 3 days in the TRIS-barbital buffer. An inter-laboratory exchange program conducted with another French hospital showed good agreement between results. In our database, <20% GF levels were scarce, compatible with the low prevalence of Still's disease, MAS, and Gaucher disease. The 95% confidence interval for GF was [26-58]%, lower than values described in the literature for healthy individuals.
    Conclusion: Thanks to good performances, this technique can become readily available for laboratories servicing patients with AOSD, MAS (including severe COVID-19 patients) and Gaucher disease patients.
    MeSH term(s) Biomarkers/blood ; Biomarkers/metabolism ; Chemistry Techniques, Analytical/methods ; Concanavalin A/metabolism ; Ferritins/blood ; Ferritins/metabolism ; Gaucher Disease/blood ; Gaucher Disease/metabolism ; Humans ; Macrophage Activation Syndrome/blood ; Macrophage Activation Syndrome/metabolism ; Protein Binding ; Still's Disease, Adult-Onset/blood ; Still's Disease, Adult-Onset/metabolism
    Chemical Substances Biomarkers ; glycosylated ferritin ; Concanavalin A (11028-71-0) ; Ferritins (9007-73-2)
    Language English
    Publishing date 2022-02-26
    Publishing country Netherlands
    Document type Evaluation Study ; Journal Article
    ZDB-ID 1180823-8
    ISSN 1873-376X ; 0378-4347 ; 1570-0232 ; 1387-2273
    ISSN (online) 1873-376X
    ISSN 0378-4347 ; 1570-0232 ; 1387-2273
    DOI 10.1016/j.jchromb.2022.123184
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Urinary proteins: up-to-date reference methods for urinary protein analysis.

    Boutten, Anne / Delatour, Vincent

    Annales de biologie clinique

    2018  Volume 76, Issue 6, Page(s) 638–642

    Abstract: Measurement of urine albumin has been introduced in the new classification of kidney disease (KD) as a marker for detecting, monitoring and predicting KD. Currently, the measure is not standardized. The variability of results obtained with commercially ... ...

    Title translation Actualités sur les méthodes de référence pour le dosage des protéines urinaires.
    Abstract Measurement of urine albumin has been introduced in the new classification of kidney disease (KD) as a marker for detecting, monitoring and predicting KD. Currently, the measure is not standardized. The variability of results obtained with commercially available procedures is important and can lead to misclassification of patients. Analytical standardization, started in 2007, is in progress. SRM 2925 primary reference material, SRM 3666 secondary reference material and liquid chromatography isotope dilution mass spectroscopy (LC-IDMS) reference measurement procedure are being validated by the National Institute of Standards and Technology (NIST). This report presents strategies and difficulties for developing this reference system.
    MeSH term(s) Albuminuria/diagnosis ; Albuminuria/urine ; Chromatography, Liquid/methods ; Chromatography, Liquid/standards ; France ; Humans ; Japan ; Proteinuria/diagnosis ; Proteinuria/urine ; Reference Standards ; Tandem Mass Spectrometry/methods ; Tandem Mass Spectrometry/standards ; Urinalysis/methods ; Urinalysis/standards ; Urine Specimen Collection/standards
    Language English
    Publishing date 2018-12-13
    Publishing country France
    Document type Journal Article
    ZDB-ID 2023584-7
    ISSN 1950-6112 ; 0003-3898
    ISSN (online) 1950-6112
    ISSN 0003-3898
    DOI 10.1684/abc.2018.1391
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Delayed increase of plasma selenoproteins and absence of side effect induced by infusion of pharmacological dose of sodium selenite in septic shock: Secondary analysis of a multicenter, randomized controlled trial.

    Forceville, Xavier / Laviolle, Bruno / Gromadzinska, Jolanta / Boutten, Anne / Van Antwerpen, Pierre / Plouvier, Elisabeth / Annane, Djillali / Bellissant, Eric

    Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)

    2022  Volume 73, Page(s) 127031

    Abstract: Background: In sepsis, neutrophil respiratory bursts participate in endothelium damage, the first step to multiple organ failure. In plasma two antioxidant selenoenzymes, which protect the endothelium, decrease: selenoprotein-P, and to a lesser extent ... ...

    Abstract Background: In sepsis, neutrophil respiratory bursts participate in endothelium damage, the first step to multiple organ failure. In plasma two antioxidant selenoenzymes, which protect the endothelium, decrease: selenoprotein-P, and to a lesser extent glutathione peroxidase (GPX3). Sodium selenite (Na
    Main results: At baseline, plasma Se was about a quarter of reference values. From baseline to day-4 plasma Se, selenoprotein-P and GPX3 significantly increased by 3.9, 2.7 and 1.8 respectively in the Na
    Conclusion: Continuous infusion of Na
    MeSH term(s) Glutathione Peroxidase ; Humans ; Lactates/therapeutic use ; Quality of Life ; Respiratory Distress Syndrome ; Selenium ; Selenoprotein P ; Selenoproteins ; Shock, Septic/drug therapy ; Sodium Selenite/pharmacology ; Sodium Selenite/therapeutic use
    Chemical Substances Lactates ; Selenoprotein P ; Selenoproteins ; Glutathione Peroxidase (EC 1.11.1.9) ; Selenium (H6241UJ22B) ; Sodium Selenite (HIW548RQ3W)
    Language English
    Publishing date 2022-06-27
    Publishing country Germany
    Document type Journal Article ; Multicenter Study ; Randomized Controlled Trial
    ZDB-ID 1236267-0
    ISSN 1878-3252 ; 1611-602X ; 0946-672X
    ISSN (online) 1878-3252 ; 1611-602X
    ISSN 0946-672X
    DOI 10.1016/j.jtemb.2022.127031
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Clinically relevant urine creatinine underestimation in the low concentration range on the Siemens Dimension Vista®.

    Raynor, Alexandre / Raulet-Bussian, Célia / Robert-Mercier, Tiphaine / Bruneel, Arnaud / Vidal-Petiot, Emmanuelle / Flamant, Martin / Boutten, Anne

    Clinical biochemistry

    2022  

    Abstract: While considerable efforts have been accomplished to standardize the measurement of plasma creatinine (PCr), urine creatinine (UCr) has not been subject to the same scrutiny. UCr is importantly used when measuring biomarkers in spot urines, to assess ... ...

    Abstract While considerable efforts have been accomplished to standardize the measurement of plasma creatinine (PCr), urine creatinine (UCr) has not been subject to the same scrutiny. UCr is importantly used when measuring biomarkers in spot urines, to assess urine output and variable dilution of urine samples. Here, we report underestimation of Jaffe UCr measurements on the Siemens Dimension Vista® analyzer, critically affecting samples with UCr ≤2 mmol/L. We demonstrate that this error is caused by automatic urine pre-dilution by the Vista's «urine mode», and that UCr measured in «plasma mode» without pre-dilution does not present this error. In the absence of a comprehensive solution proposed by Siemens, we propose simple formulae that can be easily implemented in a laboratory to correct these low UCr measurements. Importantly, the observed UCr underestimation can significantly influence reported results for biomarkers/UCr ratios measured in spot urine. Indeed, these results can be overestimated up to +84.4 % before correction using our formulae. This can sometimes lead to misclassification according to clinical thresholds, e.g. Kidney disease: improving global outcomes (KDIGO) guidelines for urine albumin/creatinine. This highlights the need for every clinical laboratory to assess the detection limits of their assays, including for lesser-discussed parameters such as UCr. Indeed, the error we reported here may affect other urine assays performing systematic urine pre-dilution and could have significant repercussions on the clinical management of patients.
    Language English
    Publishing date 2022-11-08
    Publishing country United States
    Document type Journal Article
    ZDB-ID 390372-2
    ISSN 1873-2933 ; 0009-9120
    ISSN (online) 1873-2933
    ISSN 0009-9120
    DOI 10.1016/j.clinbiochem.2022.10.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Evaluation of iron metabolism in hospitalized COVID-19 patients.

    Lefebvre, Thibaud / Boutten, Anne / Raulet-Bussian, Célia / Raynor, Alexandre / Manceau, Hana / Puy, Hervé / Moulouel, Boualem / Schmitt, Caroline / Timsit, Jean-François / Lefort, Agnès / Weiss, Emmanuel / Lescure, Francois-Xavier / Ricard, Jean-Damien / Sonneville, Romain / Peoc'h, Katell

    Clinica chimica acta; international journal of clinical chemistry

    2023  Volume 548, Page(s) 117509

    Abstract: Background: Iron metabolism dysregulation may play a role in organ failure observed in Coronavirus disease 2019 (COVID-19). This study aimed to explore the whole iron metabolism in hospitalized COVID-19 patients and evaluate the impact of tocilizumab.!## ...

    Abstract Background: Iron metabolism dysregulation may play a role in organ failure observed in Coronavirus disease 2019 (COVID-19). This study aimed to explore the whole iron metabolism in hospitalized COVID-19 patients and evaluate the impact of tocilizumab.
    Methods: We performed an observational multicentric cohort study, including patients with PCR-provenCOVID-19 from the intensive care unit (ICU) (n = 66) and medical ward (n = 38). We measured serum interleukin-6 (IL-6), ferritin, glycosylated ferritin (GF), transferrin, iron, and hepcidin. The primary outcome was death.
    Results: Among the 104 patients, we observed decreased median GF percentage (35 %; IQ 23-51.5), low iron concentration (7.5 μmol/L; IQ 4-14), normal but low transferrin saturation (TSAT; 21%; IQ 11-33) and increased median hepcidin concentration (58.7 ng/mL; IQ 20.1-92.1). IL-6, ferritin, and GF were independently and significantly associated with death (p = 0.026, p = 0.023, and p = 0.009, respectively). Surprisingly, we observed a decorrelation between hepcidin and IL-6 concentrations in some patients. These findings were amplified in tocilizumab-treated patients.
    Conclusion: Iron metabolism is profoundly modified in COVID-19. The pattern we observed presents differences with a typical inflammation profile. We observed uncoupled IL-6/hepcidin levels in some patients. The benefit of additive iron chelation therapy should be questionable in this setting.
    MeSH term(s) Humans ; Hepcidins/metabolism ; Cohort Studies ; Interleukin-6 ; COVID-19 ; Iron ; Ferritins ; Transferrin/metabolism
    Chemical Substances Hepcidins ; Interleukin-6 ; Iron (E1UOL152H7) ; Ferritins (9007-73-2) ; Transferrin
    Language English
    Publishing date 2023-08-05
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 80228-1
    ISSN 1873-3492 ; 0009-8981
    ISSN (online) 1873-3492
    ISSN 0009-8981
    DOI 10.1016/j.cca.2023.117509
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Multisystem inflammatory syndrome in children: Inputs of BNP, NT-proBNP and Galectin-3.

    Raynor, Alexandre / Vallée, Clarisse / Belkarfa, Anne-Laure / Lunte, Klara / Laney, Maude / Belhadjer, Zahra / Vicca, Stéphanie / Boutten, Anne / Bonnet, Damien / Nivet-Antoine, Valérie

    Clinica chimica acta; international journal of clinical chemistry

    2022  Volume 529, Page(s) 109–113

    Abstract: Background: Since the COVID-19 pandemic began, a cohort of Multisystem inflammatory syndrome in children (MIS-C) patients has been described. Cardiac involvement is found in 80-85% patients, typically with cardiac dysfunction with or without cardiogenic ...

    Abstract Background: Since the COVID-19 pandemic began, a cohort of Multisystem inflammatory syndrome in children (MIS-C) patients has been described. Cardiac involvement is found in 80-85% patients, typically with cardiac dysfunction with or without cardiogenic shock. Here, three cardiac biomarkers, BNP, NT-proBNP and Galectin-3 were compared for the first time in MIS-C in a unique cohort of hospitalized French children.
    Methods: Fourteen children with MIS-C hospitalized at Necker-Enfants Malades for cardiac management during the first three COVID-19 waves (March 2020-March 2021) were included. All had positive SARS-CoV-2 serology and proven cardiac involvement assessed by transthoracic echocardiography. NT-proBNP, BNP and Galectin-3 were measured at admission, discharge and first follow-up clinic.
    Results: All admission Galectin-3 measurements were comprised within the reference interval, both in patients with and without cardiogenic shock, and did not vary between admission, discharge and first follow-up clinic. Both median admission BNP and NT-proBNP were higher in children with cardiogenic shock than without. Median admission NT-proBNP was higher than its predictive positive value in heart failure in both groups of children, while median BNP was below its negative predictive value in children without cardiogenic shock but with cardiac dysfunction.
    Conclusions: Galectin-3 does not seem affected by MIS-C. NT-proBNP seems to increase more precociously than BNP possibly making it a more sensitive marker for screening of heart failure in MIS-C.
    MeSH term(s) Biomarkers ; COVID-19/complications ; Child ; Galectin 3 ; Heart Failure ; Humans ; Natriuretic Peptide, Brain ; Pandemics ; Peptide Fragments ; SARS-CoV-2 ; Systemic Inflammatory Response Syndrome
    Chemical Substances Biomarkers ; Galectin 3 ; Peptide Fragments ; pro-brain natriuretic peptide (1-76) ; Natriuretic Peptide, Brain (114471-18-0)
    Language English
    Publishing date 2022-02-18
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 80228-1
    ISSN 1873-3492 ; 0009-8981
    ISSN (online) 1873-3492
    ISSN 0009-8981
    DOI 10.1016/j.cca.2022.02.011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: The Perioperative Kinetics Profile of Troponin I in Lung Transplantation - A Pilot Observational Study.

    Andrei, Stefan / Tran-Dinh, Alexy / Boutten, Anne / Asssadi, Maksud / Tashk, Parvine / Castier, Yves / Popescu, Bogdan Alexandru / Bunel, Vincent / Tanaka, Sébastien / Montravers, Philippe / Augustin, Pascal

    Journal of cardiothoracic and vascular anesthesia

    2022  Volume 36, Issue 8 Pt A, Page(s) 2842–2845

    MeSH term(s) Biomarkers ; Humans ; Kinetics ; Lung Transplantation ; Pilot Projects ; Troponin I ; Troponin T
    Chemical Substances Biomarkers ; Troponin I ; Troponin T
    Language English
    Publishing date 2022-03-26
    Publishing country United States
    Document type Letter ; Observational Study
    ZDB-ID 1067317-9
    ISSN 1532-8422 ; 1053-0770
    ISSN (online) 1532-8422
    ISSN 1053-0770
    DOI 10.1053/j.jvca.2022.03.026
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Relationship between liver dysfunction, lipoprotein concentration and mortality during sepsis.

    Tanaka, Sébastien / De Tymowski, Christian / Stern, Jules / Bouzid, Donia / Zappella, Nathalie / Snauwaert, Aurélie / Robert, Tiphaine / Lortat-Jacob, Brice / Tran-Dinh, Alexy / Augustin, Pascal / Boutten, Anne / Tashk, Parvine / Peoc'h, Katell / Meilhac, Olivier / Montravers, Philippe

    PloS one

    2022  Volume 17, Issue 8, Page(s) e0272352

    Abstract: Background: High-density lipoproteins (HDLs) are synthesized by the liver and display endothelioprotective properties, including anti-inflammatory, antiapoptotic, antithrombotic and antioxidant effects. In both septic and chronic liver failure patients, ...

    Abstract Background: High-density lipoproteins (HDLs) are synthesized by the liver and display endothelioprotective properties, including anti-inflammatory, antiapoptotic, antithrombotic and antioxidant effects. In both septic and chronic liver failure patients, a low HDL cholesterol (HDL-C) concentration is associated with overmortality. Whereas sepsis-associated liver dysfunction is poorly defined, the aim of this study was to characterize the relationship between liver dysfunction, lipoprotein concentrations and mortality in septic patients in the intensive care unit (ICU).
    Methods: A prospective observational study was conducted in a university hospital ICU. All consecutive patients admitted for septic shock or sepsis were included. Total cholesterol, HDL-C, low-density lipoprotein-cholesterol (LDL-C), and triglyceride levels were assessed at admission. Sepsis-associated liver dysfunction was defined as a serum bilirubin≥ 2N or aspartate aminotransferase/alanine aminotransferase concentrations ≥ 2N. Short-term and one-year prognostic outcomes were prospectively assessed.
    Results: A total of 219 septic patients were included, and 15% of them presented with sepsis-associated liver dysfunction at admission. Low concentrations of lipoproteins were associated with mortality at Day 28 in the overall population. Sepsis-associated liver dysfunction at admission was associated with overmortality. In this subgroup, patients had a lower HDL-C concentration than patients without hepatic dysfunction (HDL-C = 0.31 [0.25, 0.55] mmol/L vs. 0.48 [0.29, 0.73] mmol/L, p = 0.0079) but there was no relationship with the outcome. Interestingly, no correlation was observed between lipoprotein concentrations and liver dysfunction markers.
    Conclusion: Sepsis-associated liver dysfunction at ICU admission is strongly associated with overmortality and is associated with a lower HDL-C concentration. However, in this subgroup of patients, HDL-C concentration had no relationship with mortality. Further exploratory studies are needed to better understand the interaction between lipoproteins and liver dysfunction during sepsis.
    MeSH term(s) Cholesterol, HDL ; Cholesterol, LDL ; Humans ; Lipoproteins ; Liver Diseases ; Sepsis ; Shock, Septic
    Chemical Substances Cholesterol, HDL ; Cholesterol, LDL ; Lipoproteins
    Language English
    Publishing date 2022-08-22
    Publishing country United States
    Document type Journal Article ; Observational Study
    ZDB-ID 2267670-3
    ISSN 1932-6203 ; 1932-6203
    ISSN (online) 1932-6203
    ISSN 1932-6203
    DOI 10.1371/journal.pone.0272352
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: The Prognostic Role of Early Postoperative Troponin I in Lung Transplantation-A Retrospective 7-Year Analysis.

    Andrei, Stefan / Kantor, Elie / Asssadi, Maksud / Boutten, Anne / Pellenc, Quentin / Jebrak, Gilles / Godement, Mathieu / Abbas, Samia / Atchade, Enora / Tran-Dinh, Alexy / Robert-Mercier, Tiphaine / Valeanu, Liana / Longrois, Dan / Montravers, Philippe / Augustin, Pascal

    Journal of cardiothoracic and vascular anesthesia

    2021  Volume 36, Issue 8 Pt A, Page(s) 2328–2334

    Abstract: Objectives: Postoperative cardiac troponin I concentration is predictive of worsened outcomes in cardiac surgery. Lung transplantation (LT) surgery shares common features with cardiac surgery, but postoperative troponin has yet to be investigated. The ... ...

    Abstract Objectives: Postoperative cardiac troponin I concentration is predictive of worsened outcomes in cardiac surgery. Lung transplantation (LT) surgery shares common features with cardiac surgery, but postoperative troponin has yet to be investigated. The authors aimed to evaluate the association between early postoperative troponin concentration and the 1-year mortality after transplantation.
    Design: A retrospective, observational, single-center study.
    Setting: At a tertiary care, university hospital.
    Participants: Patients who underwent lung transplantation from January 2011 to December 2017 INTERVENTIONS: For each patient, preoperative, intraoperative, and postoperative data were collected, as well as the troponin I measurement at the moment of postoperative intensive care unit admission.
    Measurements and main results: Two hundred twenty LT procedures were analyzed. Troponin I was elevated in all LT patients, with a median of 3.82 ng/mL
    Conclusion: Early postoperative troponin serum levels were not independently associated with 1-year mortality. Early postoperative troponin I levels were correlated to bilateral LT, the need for ECLS, and intraoperative blood transfusion.
    MeSH term(s) Humans ; Lung Transplantation/adverse effects ; Postoperative Complications ; Postoperative Period ; Prognosis ; Retrospective Studies ; Troponin I
    Chemical Substances Troponin I
    Language English
    Publishing date 2021-11-11
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1067317-9
    ISSN 1532-8422 ; 1053-0770
    ISSN (online) 1532-8422
    ISSN 1053-0770
    DOI 10.1053/j.jvca.2021.11.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top